ARID1A and TERT promoter mutations in dedifferentiated meningioma

While WHO grade I meningiomas are considered benign, patients with WHO grade III meningiomas have very high mortality. The principles underlying tumor progression in meningioma are largely unknown yet a detailed understanding of these mechanisms will be required for effective management of patients...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Genet
Main Authors: Abedalthagafi, Malak S., Bi, Wenya Linda, Merrill, Parker H., Gibson, William J., Rose, Matthew F., Du, Ziming, Francis, Joshua M., Du, Rose, Dunn, Ian F., Ligon, Azra H., Beroukhim, Rameen, Santagata, Sandro
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4882906/
https://ncbi.nlm.nih.gov/pubmed/25963524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cancergen.2015.03.005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares